Výsledky vyhledávání - "Nina Krisper"

Akademický článek

High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34‐positive AML

Autor: Shruti Daga, Angelika Rosenberger, Franz Quehenberger, Nina Krisper, Barbara Prietl, Andreas Reinisch, Armin Zebisch, Heinz Sill, Albert Wölfler

Publikováno v: Cancer Medicine, Vol 8, Iss 4, Pp 1771-1778 (2019)

Abstract Acute myeloid leukemia (AML) is driven by a minor fraction of leukemic stem cells (LSCs) whose persistence is considered being the primary cause of disease relapse. A detailed characterization of the surface immunophenotype of LSCs to discri

Externí odkaz: https://doaj.org/article/04d90a6c94de47319cc3b03fe10b2578

Zobrazit plný text záznamu

Plný text ve formátu HTML

High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34‐positive AML

Autor: Nina Krisper, Franz Quehenberger, Albert Wölfler, Angelika Rosenberger, Shruti Daga, Andreas Reinisch, Heinz Sill, Barbara Prietl, Armin Zebisch

Publikováno v: Cancer Medicine, Vol 8, Iss 4, Pp 1771-1778 (2019)
Cancer Medicine

Acute myeloid leukemia (AML) is driven by a minor fraction of leukemic stem cells (LSCs) whose persistence is considered being the primary cause of disease relapse. A detailed characterization of the surface immunophenotype of LSCs to discriminate th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::456a3a6074da8766d63b7bffefae33f0
https://doaj.org/article/04d90a6c94de47319cc3b03fe10b2578

Zobrazit plný text záznamu

Plný text ve formátu HTML

Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling

Autor: Angelika Rosenberger, Franz Quehenberger, Gerald Höfler, Nina Krisper, Shruti Daga, Ricarda Graf, Iris Halbwedl, Ellen Heitzer, Andreas Reinisch, Heinz Sill, Barbara Prietl, Armin Zebisch, Albert Wölfler, Karl Kashofer

Publikováno v: American Journal of Hematology

Persistent measurable residual disease (MRD) is an increasingly important prognostic marker in acute myeloid leukemia (AML). Currently, MRD is determined by multi-parameter flow cytometry (MFC) or PCR-based methods detecting leukemia-specific fusion

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::159c108dbd2c41e8fab3a06b5d51f982
https://pubmed.ncbi.nlm.nih.gov/32602117

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání